Cooperative Agreement NU52PS004711

The Minnesota Department of Health (MDH) has been awarded a $981,131 cooperative agreement from the Centers for Disease Control and Prevention (CDC) under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116). The purpose of this 5-year project is to complement the state's tuberculosis (TB) prevention and control efforts across key program areas, including TB surveillance, case oversight, treatment and nurse case management, contact investigation, drug...

This $100,316 Cooperative Agreement award from the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940) supports the Chicago Department of Public Health (CDPH) Tuberculosis Elimination Program. The program aims to save lives and improve health by curing and preventing tuberculosis (TB) among Chicago residents and visitors. Key activities include nurse case management,...

This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940) provides $381,768 to the County of San Diego Public Health Services Division to reduce tuberculosis (TB) morbidity and mortality in San Diego County. The funding supports a comprehensive set of strategies, including diagnosis and treatment of TB disease, contact investigations, testing and treatment of high-risk...

This Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940) will provide $483,911 to the Colorado Department of Public Health & Environment (CDPHE) to support comprehensive tuberculosis (TB) elimination and laboratory services in Colorado. The key objectives are to: 1) Identify and fully treat persons with active TB disease; 2) Treat individuals diagnosed with latent TB infection; 3)...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $766,877 to Albert Einstein College of Medicine to conduct a randomized controlled trial investigating the use of therapeutic drug monitoring (TDM) to prevent premature discontinuation of the antibiotic linezolid in the treatment of rifampin-resistant tuberculosis (RR-TB). The study will enroll 280 participants...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116), provides $3,393,862 to the New York City Department of Health and Mental Hygiene to support comprehensive tuberculosis (TB) prevention, control, and elimination efforts in New York City. Key products and services to be delivered under this 5-year award include: 1) Providing TB case management and...

This $300,000 cooperative agreement from the Centers for Disease Control and Prevention under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116) will support the Florida Department of Health in strengthening civil surgeons' capacity for latent tuberculosis infection (LTBI) surveillance and treatment of status adjusters. The Florida Civil Surgeon TB Consortium, comprising the Florida Department of Health TB Control Section, Miami-Dade Health...

The Health Services Kentucky Cabinet For has been awarded a $438,214 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116). The purpose of this five-year cooperative agreement is to ensure core tuberculosis (TB) program activities are implemented to meet the needs of TB prevention, control, and elimination throughout the Commonwealth of Kentucky. Key objectives include...

The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $1,601,430 Cooperative Agreement to the Washington State Department of Health under the "Project Grants and Cooperative Agreements for Tuberculosis Control Programs" (CFDA 93.116) to facilitate the elimination of tuberculosis (TB) morbidity and mortality in Washington state from 2025 to 2029. The key objectives of the Cooperative Agreement are to: 1) identify and treat active TB cases, 2) implement targeted testing...

This federal Project Grant award, valued at $774,881, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant aims to develop pro-apoptotic (cell death-inducing) drugs as host-directed therapies to shorten treatment for drug-susceptible and multi-drug resistant pulmonary tuberculosis (TB), as well as prevent post-TB lung disease. The project will leverage advanced in vivo imaging...